about
Approach to Hypertrophic Cardiomyopathy.Syncope and risk of sudden death in hypertrophic cardiomyopathy.Noninvasive assessment of myocardial perfusion: preliminary results in patients with acute myocardial infarction.Role of echocardiography in acute chest pain syndrome.Management of hypertrophic cardiomyopathy.Unexpectedly low mutation rates in beta-myosin heavy chain and cardiac myosin binding protein genes in Italian patients with hypertrophic cardiomyopathy.Virilizing leydig-sertoli cell ovarian tumor associated with endometrioid carcinoma of the endometrium in a postmenopausal patient: case report and general considerations.Erythropoietin and the heart: facts and perspectives.IGF-1 and atherothrombosis: relevance to pathophysiology and therapy.Arterial thrombotic events and acute coronary syndromes with cancer drugs: are growth factors the missed link?: what both cardiologist and oncologist should know about novel angiogenesis inhibitors.Growth factors in preeclampsia: a vascular disease model. A failed vasodilation and angiogenic challenge from pregnancy onwards?Pathogenesis of chronic cardiorenal syndrome: is there a role for oxidative stress?Hypertension in pregnancy: the most recent findings in pathophysiology, diagnosis and therapy.Spatial QT Dispersion Predicts Nonsustained Ventricular Tachycardia and Correlates with Confined Systodiastolic Dysfunction in Hypertrophic Cardiomyopathy.Patterns of left ventricular longitudinal strain and strain rate in Olympic athletes.Isoleucyl-tRNA synthetase levels modulate the penetrance of a homoplasmic m.4277T>C mitochondrial tRNA(Ile) mutation causing hypertrophic cardiomyopathy.Cardiomyopathies due to homoplasmic mitochondrial tRNA mutations: morphologic and molecular features.Hypertrophic cardiomyopathy: Authors' reply.Novel α-galactosidase A mutation in patients with severe cardiac manifestations of Fabry disease.Juvenile sudden death in a family with polymorphic ventricular arrhythmias caused by a novel RyR2 gene mutation: evidence of specific morphological substrates.Left ventricular myocardial function in myotonic dystrophy.[Cardiologic assessment of surviving family members of young victims of sudden cardiac death: diagnostic yield].Significance of Late Gadolinium Enhancement at Right Ventricular Attachment to Ventricular Septum in Patients With Hypertrophic Cardiomyopathy.Clinical impact of nonsustained ventricular tachycardia recorded by the implantable cardioverter-defibrillator in patients with hypertrophic cardiomyopathy.Maternally inherited cardiomyopathy: clinical and molecular characterization of a large kindred harboring the A4300G point mutation in mitochondrial deoxyribonucleic acid.Late gadolinium enhancement score (LGE-Score) for prediction of extensive late gadolinium enhancement in hypertrophic cardiomyopathy.Significance of sarcomere gene mutations analysis in the end-stage phase of hypertrophic cardiomyopathyPrognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathyRisk of sudden death and outcome in patients with hypertrophic cardiomyopathy with benign presentation and without risk factorsAdherence to antiplatelet therapy after percutaneous coronary interventionAssessment and Significance of Left Ventricular Mass by Cardiovascular Magnetic Resonance in Hypertrophic CardiomyopathyDynamic electrocardiographic changes in patients with arrhythmogenic right ventricular cardiomyopathyHyperthrophic cardiomyopathy and thePTPN11 genePrevention of Sudden Cardiac Death With Implantable Cardioverter-Defibrillators in Children and Adolescents With Hypertrophic CardiomyopathyAntimitochondrial autoantibodies in myocardial hypertrophy: Comparison between hypertrophic cardiomyopathy, hypertensive heart disease, and athlete's heartHLA-DR3 antigen linkage in patients with hypertrophic obstructive cardiomyopathyPulmonary embolism in pregnancyEligibility for the Subcutaneous Implantable Cardioverter-Defibrillator in Patients With Hypertrophic CardiomyopathyElectrocardiographic evolution in patients with hypertrophic cardiomyopathy who develop a left ventricular apical aneurysmRestrictive cardiomyopathy and pseudoxanthoma elasticum skin lesions
P50
Q33151971-AD742EF3-00A9-47DD-8F04-06FB6057E798Q33157231-56986C64-4B99-4192-A7C1-93EBA3576F71Q34039361-ACDCC6E9-AE2B-4651-8FCC-B84A2AE9F1FEQ34039379-420D01A6-217B-41DC-9070-B4BA25BDAC4DQ34647057-EF21B349-7CB3-4D4B-B5EC-B6CD714782A0Q35590181-35603E00-1F51-4211-862C-A81AF3041F62Q36371563-F9858C36-AF83-4043-977C-579F1EF295D8Q37798565-A3416F2F-B0F2-4D21-9316-197E3E88F2ADQ37829755-0A16E20D-7DF8-4E48-8BF1-12DCD7D69BA2Q38082019-DA838AF5-0242-434E-959D-7538A5151693Q38117020-54C05C2C-CC3C-4190-BB77-F36A790B07D5Q38165049-DF9267D4-DE5C-48A0-A5E0-F2CD24D8DB8AQ38191121-227EC6F4-F098-40D1-A888-7547517A6822Q40996134-E1ACEEAE-8AD3-43FA-9023-E63EA4768738Q41748441-0AF2FE69-3360-4C32-A14A-E6C9FA7DB540Q44094488-21343D46-E999-4EE5-A69A-D107EDFC71D0Q45010791-D2C377FA-CC1B-4427-AA3A-FDE136EBC857Q46467320-6750EAF1-47DD-4254-AE44-B649A2E59165Q46596820-4F724300-3DF5-416A-811E-8223E02CCC3FQ46638582-D23F7FF9-9EEB-44CD-9EFD-4C46CA1FE155Q51059337-801BD316-DE9D-4187-8DC5-E2C1868998B1Q51154097-695147AD-5003-47C6-8326-86E378EDFE06Q53485268-50BD0680-110B-4228-B682-68DEDCE4940EQ53489965-740D83CD-1FE0-4D68-9C9E-300BB3DAD76FQ54238570-A0F7DA85-F803-4306-BE2D-31985912D4B5Q55643045-96C6E07E-ACD2-4808-B329-E661FC66BBCBQ56972986-B1670EE9-3AC4-4225-9F13-9D1FC1D97D72Q56973319-277F2223-9B30-4689-8202-BB3D2823D4CFQ56974456-152AA1C7-20CA-4A49-816E-354311D7F6C8Q57209625-5D7B200B-FD64-4EC8-A634-FBFA4C77B5A1Q57841280-140FA188-BFDA-465C-9B92-3395ED1F1B62Q57901826-8A215F68-7AC0-4CDB-A2B2-9F56A0043786Q58193679-7508B544-1A98-4E89-9770-FF2714F89C9AQ58819141-F65CFFDF-F83D-4438-BD7A-E1378DFF42D2Q58880485-2AD567E1-F6CA-45E9-980D-D9F99182A4BEQ58880505-106A129E-8226-4414-9794-84E77029ED66Q61783467-AD5A92D8-BFA4-4AA4-B484-E62B1E4C4950Q61865846-DEAE41CC-0AAB-4520-B692-1FE5CA71D87FQ61865848-D8E06CD1-1E46-4C51-9310-1EE3F54B5A9CQ61865875-2A8F6193-8B3D-4BA0-BA74-A6C20C2A2963
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Camillo Autore
@ast
Camillo Autore
@en
Camillo Autore
@es
Camillo Autore
@nl
type
label
Camillo Autore
@ast
Camillo Autore
@en
Camillo Autore
@es
Camillo Autore
@nl
prefLabel
Camillo Autore
@ast
Camillo Autore
@en
Camillo Autore
@es
Camillo Autore
@nl
P106
P1153
7004510006
P31
P496
0000-0002-6542-7342